Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,278 | -1,417 | 7,224 | 3,500 | 11,768 |
| Depreciation Amortization | 19,890 | 14,342 | 9,058 | 4,062 | 17,728 |
| Income taxes - deferred | -2,101 | -2,487 | -2,492 | 458 | 125 |
| Accounts receivable | -12,664 | 3,054 | -5,460 | -6,166 | -9,987 |
| Other Working Capital | -28,644 | -16,176 | -15,717 | -16,548 | -4,332 |
| Other Operating Activity | 28,702 | 6,598 | 11,752 | 6,621 | 12,874 |
| Operating Cash Flow | $1,905 | $3,914 | $4,365 | $-8,073 | $28,176 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -17,109 | -11,933 | -6,446 | -2,952 | -10,835 |
| Net Acquisitions | -145,752 | -145,803 | -38,704 | N/A | N/A |
| Purchase Sale Intangibles | -398 | -292 | -198 | -102 | -411 |
| Other Investing Activity | -398 | -292 | -198 | -102 | -411 |
| Investing Cash Flow | $-163,259 | $-158,028 | $-45,348 | $-3,054 | $-11,246 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 35,000 | N/A | N/A | N/A | 150,000 |
| Debt Repayment | -5,063 | -5,027 | -4,988 | -180 | -775 |
| Common Stock Issued | 2,313 | 2,135 | 1,519 | 1,344 | 24,627 |
| Common Stock Repurchased | -579 | -541 | -422 | -314 | -164 |
| Other Financing Activity | 1,570 | 265 | -1,085 | 660 | -36,803 |
| Financing Cash Flow | $33,241 | $-3,168 | $-4,976 | $1,510 | $136,885 |
| Exchange Rate Effect | -820 | -230 | 448 | 312 | -1,180 |
| Beginning Cash Position | 175,928 | 175,928 | 175,928 | 175,928 | 23,293 |
| End Cash Position | 46,995 | 18,416 | 130,417 | 166,623 | 175,928 |
| Net Cash Flow | $-128,933 | $-157,512 | $-45,511 | $-9,305 | $152,635 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,905 | 3,914 | 4,365 | -8,073 | 28,176 |
| Capital Expenditure | -17,189 | -12,013 | -6,446 | -2,952 | -11,135 |
| Free Cash Flow | -15,284 | -8,099 | -2,081 | -11,025 | 17,041 |